Stockreport

MIMEDX EPIFIX® Receives Reimbursement Approval in Japan

MiMedx Group, Inc  (MDXG) 
Last mimedx group, inc earnings: 4/28 07:00 am Check Earnings Report
PDF Provides Favorable Access to a New $500 Million Market for the Treatment of Refractory Diabetic and Venous Ulcers for EPIFIX – the First and Only Amniotic Tissue Product [Read more]